G0532 Insurance Policy Changes

HCPCS G0532 is officially defined as "Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)." HCPCS G0532 is referenced in 2 tracked payer policy changes from Kansas Medicaid (KanCare). For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0532 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.